$RXO
RXO, Inc.

2024 Q3 Form 10-Q Financial Statement

#000192956124000102 Filed on August 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $1.040B $930.0M
YoY Change 6.56% -3.43%
Cost Of Revenue $858.0M $750.0M
YoY Change 7.12% -4.09%
Gross Profit $182.0M $180.0M
YoY Change 4.0% -0.55%
Gross Profit Margin 17.5% 19.35%
Selling, General & Admin $149.0M $154.0M
YoY Change 0.68% 6.94%
% of Gross Profit 81.87% 85.56%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $21.00M $17.00M
YoY Change 31.25% -5.56%
% of Gross Profit 11.54% 9.44%
Operating Expenses $149.0M $154.0M
YoY Change 0.68% -4.94%
Operating Profit -$20.00M $0.00
YoY Change -433.33% -100.0%
Interest Expense -$6.000M -$8.000M
YoY Change -25.0% 0.0%
% of Operating Profit
Other Income/Expense, Net -$216.0M $0.00
YoY Change 21500.0%
Pretax Income -$242.0M -$8.000M
YoY Change 7966.67% -233.33%
Income Tax $1.000M -$1.000M
% Of Pretax Income
Net Earnings -$243.0M -$7.000M
YoY Change 24200.0% -333.33%
Net Earnings / Revenue -23.37% -0.75%
Basic Earnings Per Share -$1.81 -$0.06
Diluted Earnings Per Share -$1.81 -$0.06
COMMON SHARES
Basic Shares Outstanding 117.6M shares 117.5M shares
Diluted Shares Outstanding 134.1M shares 117.6M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $55.00M $7.000M
YoY Change -47.12% -94.35%
Cash & Equivalents $55.00M $7.000M
Short-Term Investments
Other Short-Term Assets $62.00M $44.00M
YoY Change 37.78% -10.2%
Inventory
Prepaid Expenses
Receivables $1.138B $725.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.255B $776.0M
YoY Change 34.08% -15.28%
LONG-TERM ASSETS
Property, Plant & Equipment $175.0M $328.0M
YoY Change -40.68% 17.14%
Goodwill $1.027B $630.0M
YoY Change 63.02% 0.0%
Intangibles $565.0M $62.00M
YoY Change 684.72% -15.07%
Long-Term Investments
YoY Change
Other Assets $37.00M $17.00M
YoY Change 184.62% 30.77%
Total Long-Term Assets $2.137B $1.037B
YoY Change 111.58% 4.12%
TOTAL ASSETS
Total Short-Term Assets $1.255B $776.0M
Total Long-Term Assets $2.137B $1.037B
Total Assets $3.392B $1.813B
YoY Change 74.31% -5.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $572.0M $382.0M
YoY Change 27.68% -11.57%
Accrued Expenses $262.0M $197.0M
YoY Change 18.55% -23.64%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $15.00M $16.00M
YoY Change 400.0% 300.0%
Total Short-Term Liabilities $947.0M $662.0M
YoY Change 30.08% -5.29%
LONG-TERM LIABILITIES
Long-Term Debt $352.0M $370.0M
YoY Change -21.95% -17.96%
Other Long-Term Liabilities $65.00M $42.00M
YoY Change 75.68% -73.08%
Total Long-Term Liabilities $793.0M $572.0M
YoY Change 26.27% -5.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $947.0M $662.0M
Total Long-Term Liabilities $793.0M $572.0M
Total Liabilities $1.740B $1.234B
YoY Change 28.32% -6.73%
SHAREHOLDERS EQUITY
Retained Earnings -$259.0M -$16.00M
YoY Change -6575.0% -420.0%
Common Stock $2.000M $1.000M
YoY Change 100.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.652B $579.0M
YoY Change
Total Liabilities & Shareholders Equity $3.392B $1.813B
YoY Change 74.31% -5.18%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$243.0M -$7.000M
YoY Change 24200.0% -333.33%
Depreciation, Depletion And Amortization $21.00M $17.00M
YoY Change 31.25% -5.56%
Cash From Operating Activities -$7.000M -$5.000M
YoY Change -275.0% -120.83%
INVESTING ACTIVITIES
Capital Expenditures $11.00M $11.00M
YoY Change -38.89% -31.25%
Acquisitions
YoY Change
Other Investing Activities -$1.019B
YoY Change 101800.0%
Cash From Investing Activities -$1.030B -$11.00M
YoY Change 5321.05% -31.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.085B 16.00M
YoY Change -27225.0% -420.0%
NET CHANGE
Cash From Operating Activities -7.000M -5.000M
Cash From Investing Activities -1.030B -11.00M
Cash From Financing Activities 1.085B 16.00M
Net Change In Cash 48.00M 0.000
YoY Change -352.63% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$7.000M -$5.000M
Capital Expenditures $11.00M $11.00M
Free Cash Flow -$18.00M -$16.00M
YoY Change 28.57% -300.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Other Income
OtherIncome
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-162000000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
17000000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-73000000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-59000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
66000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28000000 usd
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
1000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98000000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7000000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
49000000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
2000000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
579000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
594000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-22000000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
589000000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
963000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1843000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1973000000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
963000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1843000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1973000000 usd
CY2024Q2 us-gaap Debt Current
DebtCurrent
16000000 usd
CY2023Q2 us-gaap Other Income
OtherIncome
0 usd
us-gaap Other Income
OtherIncome
1000000 usd
us-gaap Other Income
OtherIncome
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
124000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3000000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22000000 usd
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13000000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1000000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-27000000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22000000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
119000000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
92000000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
1000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
26000000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
36000000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
21000000 usd
rxo Cash Paid For Interest
CashPaidForInterest
15000000 usd
rxo Cash Paid For Interest
CashPaidForInterest
17000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
582000000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-7000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2000000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
6000000 usd
CY2024Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
63000 shares
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2000000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
11000000 usd
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
581000 shares
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2000000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
579000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
585000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3000000 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
2000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
587000000 usd
us-gaap Net Income Loss
NetIncomeLoss
3000000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
11000000 usd
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
654000 shares
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10000000 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
2000000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
589000000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 reportingsegment
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
930000000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
930000000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
48000000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
1
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3Y
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
6000000 usd
us-gaap Restructuring Charges
RestructuringCharges
13000000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
12000000 usd
CY2024Q2 us-gaap Restructuring Reserve
RestructuringReserve
7000000 usd
CY2024Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
393000000 usd
CY2024Q2 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
386000000 usd
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
367000000 usd
CY2023Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
359000000 usd
CY2024Q2 us-gaap Debt Current
DebtCurrent
16000000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
3000000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
3000000 usd
CY2024Q2 rxo Debt Instrument Face Amount Non Current
DebtInstrumentFaceAmountNonCurrent
377000000 usd
CY2024Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
370000000 usd
CY2023Q4 rxo Debt Instrument Face Amount Non Current
DebtInstrumentFaceAmountNonCurrent
364000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
356000000 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
7000000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
8000000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7000000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7000000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3000000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-22000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3000000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
117579000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116894000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
117398000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116748000 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2563000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2666000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
117579000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119457000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
117398000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119414000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2638 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
333 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2576 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
629 shares

Files In Submission

Name View Source Status
0001929561-24-000102-index-headers.html Edgar Link pending
0001929561-24-000102-index.html Edgar Link pending
0001929561-24-000102.txt Edgar Link pending
0001929561-24-000102-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rxo-20240630.htm Edgar Link pending
rxo-20240630.xsd Edgar Link pending
rxo-20240630_g1.jpg Edgar Link pending
rxo2024q210-qexx311.htm Edgar Link pending
rxo2024q210-qexx312.htm Edgar Link pending
rxo2024q210-qexx321.htm Edgar Link pending
rxo2024q210-qexx322.htm Edgar Link pending
Show.js Edgar Link pending
rxo-20240630_cal.xml Edgar Link unprocessable
rxo-20240630_def.xml Edgar Link unprocessable
rxo-20240630_lab.xml Edgar Link unprocessable
rxo-20240630_pre.xml Edgar Link unprocessable
rxo-20240630_htm.xml Edgar Link completed